Compositions comprising propionibacterium acnes bacteriophages for treating acne
AssigneePhi Therapeutics, Inc.
InventorsYug VARMA, Nancy VAN PROOYEN
Life of this patent
Estimating the term…
Abstract
Provided herein are, inter alia, compositions, systems, and methods for preventing or treating acne. Included are compositions, combinations, systems, and methods comprising at least one Propionibacterium acnes bacteriophage, at least one anti-acne compound, and a pharmaceutically acceptable carrier. Also included are compositions, combinations, and systems comprising a Propionibacterium acnes bacteriophage and an enzyme. Methods for preventing or treating acne are also provided.
Claims33
-55. (canceled)
A composition formulated for topical administration comprising:
- (a) a PHIT-101 bacteriophage;
- (b) a dispersin enzyme;
- and
- (c) a probiotic bacteria comprising a strain of Propionibacterium acnes (P. acnes), wherein the P. acnes strain comprises 16S rDNA sequences comprising SEQ ID NO:
- 3 and SEQ ID NO:
- 4.
-61. (canceled)
A method for treating acne in a subject in need thereof, the method comprising:
- topically administering the composition of claim 77 to a region of the subject's skin comprising the acne.
A method for treating acne in a subject in need thereof, the method comprising:
- (a) topically administering a composition comprising a dispersin enzyme to a region of the subject's skin comprising the acne;
- (b) topically administering the composition of claim 77 to the region of the subject's skin comprising the acne;
- and
- (c) topically administering a composition comprising a strain of Propionibacterium acnes (P. acnes), wherein the P. acnes strain comprises 16S rDNA sequences comprising SEQ ID NO:
- 3 and SEQ ID NO:
- 4 to the region of the subject's skin comprising the acne.
(canceled)
(canceled)
A composition comprising:
- (a) at least one Propionibacterium bacteriophage, wherein the genome of the Propionibacterium bacteriophage comprises a nucleotide sequence that is at least about 90%, 95%, 96%, 97%, 98%, or 99% identical to the nucleotide sequence of SEQ ID NO:
- 1;
- (b) at least one anti-acne compound;
- and
- (c) a pharmaceutically acceptable carrier.
A composition comprising:
- at least one Propionibacterium bacteriophage, wherein the genome of the P. acnes bacteriophage comprises a nucleotide sequence that is at least about 90%, 95%, 96%, 97%, 98%, or 99% identical to the nucleotide sequence of SEQ ID NO:
- 1;
- and
- at least one compound selected from salicylic acid, benzoyl peroxide, and sulfur.
Dependencies are inferred from the claim text.